The Food and Drug Administration (FDA) has taken a hard stance on companies that illegally sell unapproved CBD products, claiming they can diagnose, cure, mitigate, treat or prevent various diseases. In some cases, the FDA has even issued warning letters to companies that have added CBD to food products. Currently, the only FDA-approved CBD product is a prescription drug used to treat rare and serious forms of epilepsy. The FDA has also issued warning letters to companies that market new unapproved drugs containing cannabidiol (CBD).
These products violate the Federal Food, Drug and Cosmetic Act (Act FD&C). It's important to note that the FDA has not approved any over-the-counter (OTC) drugs containing CBD, and none of these products meet the requirements to be legally marketed without a new approved drug application. In addition, the FDA has conducted tests on randomly selected cannabidiol (CBD) products and found that almost half of them tested positive for THC, the main active compound in marijuana. This calls into question the accuracy of labeling CBD products.
The FDA also found that many of these products did not contain the levels of CBD they claimed to contain.
Does the FDA Test CBD Products?The answer is yes. The FDA has taken a hard stance on companies that illegally sell unapproved CBD products, issuing warning letters and conducting tests on randomly selected CBD products. The tests have revealed that many of these products do not contain the levels of CBD they claim to contain, and some even contain THC.
The FDA's actions are part of an effort to evaluate CBD-containing products from a wide range of sources, including conventional foods and beverages, personal lubricants, tampons and suppositories. This could result in a more simplified process for researchers to study cannabis and its derivatives, including CBD, which fall within the definition of hemp. This could accelerate the development of new drugs containing hemp.